Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00752271 · ClinicalTrials.gov registry record
AMS Study: Inflammatory and Biomechanical Contributors to Arthritis Development Following Arthroscopic Meniscectomy
A clinical trial, sponsored by National Institute on Aging (NIA).
- Terminated
- Registry status
- 32
- Enrollment target
NCT00752271: Clinical Trial study, sponsored by National Institute on Aging (NIA).
NCT00752271 is a clinical trial that was terminated before completion, run by National Institute on Aging (NIA). The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00752271 was terminated before completion, sponsored by National Institute on Aging (NIA).
- TERMINATED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the relationship between muscle activation and heart rate on joint generalized inflammation and arthritis development.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-05 |
Why NCT00752271 stopped before completion
NCT00752271 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00752271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00752271 about?
NCT00752271 is a clinical study titled "AMS Study: Inflammatory and Biomechanical Contributors to Arthritis Development Following Arthroscopic Meniscectomy". The purpose of this study is to examine the relationship between muscle activation and heart rate on joint generalized inflammation and arthritis development.
What is the current status of trial NCT00752271?
This trial is currently terminated. The enrollment target is 32 participants. The study started on 2008-05. Estimated completion is 2010-05.
Who is sponsoring clinical trial NCT00752271?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia